pioglitazone hydrochloride and metformin hydrochloride

FDA Drug Profile

Drug Details

Generic Name
pioglitazone hydrochloride and metformin hydrochloride
Brand Names
N/A
Application Number
Sponsor
Takeda Pharmaceutical Company LTD
NDC Codes
2
Dosage Forms
TABLET
Routes
N/A
Active Ingredients
METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Pioglitazone and metformin hydrochloride tablets are not recommended to treat type 1 diabetes mellitus or diabetic ketoacidosis. Pioglitazone and metformin hydrochloride tablets are a combination of pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Not recommended for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )